InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,397.65
(
0.98%
)
Post# of 53906
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

alexander77

Send PM Follow Ignore
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

alexander77

Re: None

Friday, 07/31/2015 7:35:56 AM

Friday, July 31, 2015 7:35:56 AM

Post# of 53906
AEZS:Biotech Stocks to bet on:AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
http://wallstreetpoint.com/biotech-stocks-to-bet-on-cara-therapeutics-inc-nasdaqcara-aeterna-zentaris-inc-usa-nasdaqaezs-novavax-inc-nasdaqnvax/72921/

On the trading floor, shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) gained 1.67% to close at $0.189. The company on July 29, 2015 declared it has selected an optimized Erk inhibitor molecule for development, thus achieving another important milestone in the development of a new class of potential cancer therapies.

The MAPK pathway represents a prime target for therapeutic intervention in cancer. Recently approved compounds demonstrate important antitumor activities and survival benefits for B-Raf and Mek inhibitors. Erk inhibitors may be preferred agents in tumors with aberrant MAPK pathway activity, e.g. in tumors with mutated or wildtype B-Raf, mutated or wildtype ras, and in tumors with acquired resistance to Raf and Mek inhibitors.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up